Adaptive Biotechnologies Corporation
ADPT | NASDAQ
$27.73
-$0.13 (-0.47%)
Sep 22, 2026, 11:34 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 308.08M | 295.41M | 276.98M | 252.75M | 205.22M | 189.53M | 178.96M | 177.28M | 168.77M | 174.5M | 170.28M | 179.69M | 189.6M | 184.34M | 185.31M | 168.04M | 159.68M | 154.52M | 154.34M | 146.6M | 133.43M | 115.91M |
Cost of Revenue | 75.68M | 73.09M | 71.36M | 71.18M | 69.69M | 71.01M | 72.08M | 73.65M | 76.33M | 74.92M | 75.55M | 72.53M | 68.09M | 63.4M | 57.91M | 55.68M | 54.96M | 52.5M | 49.3M | 41.17M | 33.03M | 27.18M |
Gross Profit | 232.4M | 222.32M | 205.62M | 181.57M | 135.53M | 118.52M | 106.88M | 103.63M | 92.44M | 99.58M | 94.72M | 107.16M | 121.51M | 120.94M | 127.4M | 112.36M | 104.72M | 102.02M | 105.04M | 105.43M | 100.4M | 88.74M |
Operating Income | -37.46M | -46.73M | -57.12M | -78.19M | -121.11M | -143.39M | -162.55M | -199.78M | -218.1M | -218.6M | -227.04M | -195.15M | -189.63M | -194.31M | -200.19M | -222.6M | -233.49M | -230.75M | -208.97M | -191.61M | -172.33M | -159.48M |
Interest Income | 8.71M | 8.85M | 9.44M | 10.37M | 11.62M | 12.99M | 14.53M | 16.08M | 16.88M | 16.73M | 15.53M | 13.52M | 10M | 6.81M | 4.06M | 1.69M | 1.26M | 1.3M | 1.67M | 2.21M | 2.91M | 4.33M |
Pretax Income | -64.01M | -49.66M | -59.48M | -79.62M | -121.23M | -141.89M | -159.57M | -195.32M | -213.57M | -215.14M | -225.3M | -196.01M | -191M | -195.27M | -200.37M | -221.56M | -232.24M | -229.45M | -207.3M | -189.4M | -169.43M | -155.14M |
Net Income | -63.85M | -49.68M | -59.5M | -79.61M | -121.23M | -141.84M | -159.49M | -195.24M | -213.47M | -215.06M | -225.25M | -195.94M | -190.92M | -195.15M | -200.25M | -221.46M | -232.08M | -229.34M | -207.18M | -190.42M | -171.23M | -155.47M |
Selling & General & Admin | 180.38M | 174.16M | 167.27M | 162.87M | 159.25M | 156.1M | 157.57M | 160.57M | 163.33M | 171.29M | 172.51M | 176.03M | 177.73M | 177.03M | 184.13M | 188.03M | 190.86M | 184.66M | 169.97M | 151.87M | 133.32M | 120.61M |
Research & Development | 88.21M | 93.19M | 93.77M | 95.2M | 95.69M | 96.91M | 102.95M | 108.51M | 112.88M | 119.76M | 122.12M | 124.59M | 131.72M | 136.52M | 141.76M | 145.23M | 145.65M | 146.41M | 142.34M | 143.48M | 137.72M | 125.91M |
Other Expenses | 1.28M | 1.7M | 1.7M | 1.7M | 1.7M | 8.9M | 8.91M | 34.34M | 34.34M | 27.13M | 27.13M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M |
Operating Expenses | 269.86M | 269.04M | 262.74M | 259.76M | 256.64M | 261.91M | 269.43M | 303.41M | 310.54M | 318.18M | 321.76M | 302.32M | 311.14M | 315.25M | 327.59M | 334.96M | 338.21M | 332.77M | 314.01M | 297.04M | 272.73M | 248.21M |
Interest Expense | 11.51M | 11.76M | 11.78M | 11.78M | 11.74M | 11.49M | 11.58M | 11.64M | 12.35M | 13.26M | 13.8M | 14.37M | 11.37M | 7.77M | 4.24M | 653K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 100.71M | 97.87M | 94.57M | 91.67M | 88.75M | 85.49M | 84.76M | 85.09M | 85.03M | 88.59M | 88.58M | 90.39M | 91.41M | 91.82M | 95.6M | 98.58M | 102.02M | 100.95M | 95.47M | 87.31M | 76.84M | 67.96M |
Cost & Expenses | 345.54M | 342.13M | 334.1M | 330.94M | 326.33M | 332.92M | 341.51M | 377.06M | 386.87M | 393.11M | 397.31M | 374.84M | 379.23M | 378.65M | 385.49M | 390.64M | 393.17M | 385.28M | 363.31M | 338.21M | 305.76M | 275.39M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.12M | 1.8M | 323K |
Shares Outstanding (Basic) | 157.7M | 155.52M | 153.13M | 152.43M | 152.08M | 149.2M | 147.1M | 147.52M | 147.41M | 145.79M | 144.9M | 144.7M | 144.4M | 143.51M | 143.05M | 142.93M | 140.66M | 141.7M | 140.21M | 140.83M | 140.36M | 138.97M |
Shares Outstanding (Diluted) | 157.7M | 155.52M | 153.13M | 163.16M | 152.08M | 149.2M | 147.1M | 147.52M | 147.41M | 145.79M | 144.9M | 144.7M | 144.4M | 143.51M | 143.05M | 142.93M | 142.36M | 141.7M | 141.23M | 140.83M | 140.36M | 138.97M |
EPS (Basic) | -0.41 | -0.33 | -0.40 | -0.54 | -0.82 | -0.96 | -1.09 | -1.34 | -1.47 | -1.49 | -1.56 | -1.25 | -1.22 | -1.26 | -1.30 | -1.57 | -1.65 | -1.63 | -1.48 | -1.37 | -1.24 | -1.15 |
EPS (Diluted) | -0.41 | -0.33 | -0.40 | -0.54 | -0.82 | -0.96 | -1.09 | -1.34 | -1.47 | -1.49 | -1.56 | -1.25 | -1.22 | -1.25 | -1.29 | -1.55 | -1.63 | -1.62 | -1.47 | -1.37 | -1.24 | -1.15 |
EBITDA | -15.96M | -22.03M | -37.26M | -57.14M | -98.63M | -119.04M | -128.76M | -163.51M | -179.85M | -178.02M | -187.44M | -157.68M | -156.05M | -166.22M | -175.21M | -200.42M | -213.61M | -213.11M | -193.98M | -181.29M | -163.72M | -152.24M |
EBIT | -32.09M | -38.97M | -53.51M | -73.65M | -115.33M | -136.23M | -148.02M | -183.71M | -201.22M | -201.88M | -211.5M | -181.63M | -179.63M | -187.5M | -196.13M | -220.9M | -232.24M | -229.45M | -207.94M | -190.82M | -171.87M | -159.48M |
Depreciation & Amortization | 16.13M | 16.94M | 16.26M | 16.51M | 16.69M | 17.2M | 19.26M | 20.2M | 21.37M | 23.85M | 24.06M | 23.96M | 23.58M | 21.29M | 20.92M | 20.48M | 18.63M | 16.34M | 13.95M | 9.53M | 8.15M | 7.24M |
Add to Watchlist
Select watchlists to add or remove ADPT